PDC Therapeutics

General Information

Company Name

PDC Therapeutics

Founded Year

2020

Location (Offices)

Lausanne, Switzerland +1

Founders / Decision Makers

Number of Employees

Industries

Biotechnology

Funding Stage

Social Media

PDC Therapeutics - Company Profile

PDC Therapeutics is a biotechnology start-up founded in 2020 and headquartered in Switzerland. The company focuses on developing targeted Polymer-Drug Conjugate technologies under the proprietary Sagitta® platform, aiming to provide patients with an optimal therapeutic index. PDC Therapeutics collaborates with multinational pharmaceutical companies through co-development programs and is supported by an industry-experienced board of scientific and supervisory experts globally. The company's biodegradable conjugation platforms enable the discovery and development of therapies with versatile targeting capabilities. Currently, there is no public information available regarding the last investment or the involved investors.

Taxonomy: Polymer-Drug Conjugate, Sagitta®, Therapeutics, Nanomedicines, Cancer Therapy, Biodegradable Conjugation, Drug Delivery, Co-development Programs, Pharmaceutical Industry, Targeted Therapies, Medical Research, Drug Development, Scientific Board, Biotech Start-up